Orexin receptor market is anticipated to grow at a significant CAGR during the forecast period. Orexins are also known as hypocretins. They are two neuropeptides secreted from orexin-containing neurons, mainly in the lateral hypothalamus (LH). They play a vital regulatory role in many physiological processes such as feeding behavior, sleep–wake rhythm, reward and addiction and energy balance. The major factor driving the growth of the market is the rising prevalence of depressive disorder across the globe.
According to the National Institute of Mental Health (NHIM), in 2019, an estimated 19.4 million adults in the US had at least one major depressive episode which represented 7.8% of adults. Furthermore, according to World Health Organization (WHO), depression is a leading cause of disability globally with an estimated 3.8% of the population affected, including 5.0% among adults and 5.7% among adults older than 60 years in 2021. Hence, the increasing prevalence of the depressive disorder is driving the demand for orexin receptors owing to their application as an anti-depressant which in turn is driving the growth of the market.
Some major players in the market include Merck & Co. Inc., GlaxoSmithKline plc, and Eisai Co., Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2020, Eisai Co., Ltd. announced the launch of its in-house-discovered and developed orexin receptor antagonist DAYVIGO 2.5 mg, 5 mg, 10 mg tablets (lemborexant) in Japan. It is used for the treatment of insomnia.
To Request a Sample of our Report on Orexin Receptor Market: https://www.omrglobal.com/request-sample/orexin-receptor-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Merck & Co. Inc., GlaxoSmithKline plc, and Eisai Co., Ltd., among others.
Orexin Receptor Market Report by Segment
By Type
- Orexin 1 Receptor
- Orexin 2 Receptor
By Application
- Insomnia
- Sleep Disorders
- Major Depressive Disorder
- Other
A full Report of Orexin Receptor Market is Available @ https://www.omrglobal.com/industry-reports/orexin-receptor-market
Orexin Receptor Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
